MiMedx Correlations
MDXG Stock | USD 6.86 0.07 1.01% |
The current 90-days correlation between MiMedx Group and Axogen Inc is 0.06 (i.e., Significant diversification). The correlation of MiMedx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
MiMedx Correlation With Market
Weak diversification
The correlation between MiMedx Group and DJI is 0.39 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MiMedx Group and DJI in the same portfolio, assuming nothing else is changed.
Moving together with MiMedx Stock
Moving against MiMedx Stock
0.64 | EC | Ecopetrol SA ADR | PairCorr |
0.46 | PHJMF | PT Hanjaya Mandala | PairCorr |
0.44 | VTYX | Ventyx Biosciences | PairCorr |
0.4 | PFE | Pfizer Inc | PairCorr |
0.32 | PCVX | Vaxcyte | PairCorr |
0.37 | T | ATT Inc | PairCorr |
0.34 | MSFT | Microsoft Earnings Call This Week | PairCorr |
0.32 | GE | GE Aerospace | PairCorr |
0.31 | BAC | Bank of America Aggressive Push | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between MiMedx Stock performing well and MiMedx Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MiMedx's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
AXGN | 2.68 | (0.37) | 0.00 | (0.12) | 0.00 | 4.74 | 27.13 | |||
ENTA | 2.97 | 0.40 | 0.12 | 0.48 | 3.74 | 6.10 | 22.31 | |||
EWTX | 2.35 | 0.10 | (0.03) | 2.33 | 3.49 | 5.66 | 22.67 | |||
GLUE | 3.18 | 0.07 | 0.07 | 0.24 | 3.58 | 7.85 | 21.39 | |||
GNLX | 4.70 | 0.47 | 0.09 | 0.70 | 4.76 | 11.11 | 33.64 | |||
LYEL | 5.16 | 0.41 | 0.10 | 0.47 | 5.01 | 9.31 | 83.51 | |||
MGNX | 4.93 | 0.12 | 0.11 | 0.24 | 4.55 | 11.19 | 32.12 | |||
MRSN | 5.57 | 0.69 | 0.01 | (0.19) | 6.83 | 12.50 | 34.64 | |||
OMER | 4.40 | (0.43) | 0.00 | 0.80 | 0.00 | 7.99 | 45.23 | |||
PTGX | 1.74 | 0.12 | 0.02 | 0.39 | 2.26 | 4.44 | 14.80 |
MiMedx Corporate Management
Matthew Notarianni | Head Relations | Profile | |
Todd Newton | Interim Director | Profile | |
William Phelan | VP Officer | Profile | |
Kimberly MaerskMoller | Chief Officer | Profile | |
Kim Moller | Chief Officer | Profile | |
Rebeccah Brown | Vice Affairs | Profile |